• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

February 23, 2021

Study Links Drinking, Smoking, Drug Use With Premature Heart Disease in Youth

Author(s):

Aislinn Antrim, Assistant Editor

Recreational substance use was associated with 1.5 to 3 times higher odds of heart disease, with stronger associations among young women.

Recreational drinking, smoking, and drug use has been linked to premature heart disease in young people, especially young women, according to new research published in Heart.

According to the study, the number of new heart disease cases has been increasing among young adults, but the potential role of recreational substance use isn’t entirely clear. To investigate this, researchers explored whether the recreational use of tobacco, cannabis, alcohol, and illicit drugs, such as amphetamine and cocaine, might be associated with prematurely blocked arteries.

Investigators evaluated information supplied to the 2014-2015 nationwide Veterans Affairs Healthcare database and the Veterans with premaTure AtheroscLerosis (VITAL) registry. Extremely premature heart disease was defined as an event such as a heart attack, angina, or stroke before the age of 40, and premature heart disease was defined as an event before the age of 55 in men and before the age of 65 in women.

In total, there were 135,703 individuals with premature heart disease and 7716 with extremely premature heart disease. They were compared with patients who did not have premature heart disease.

According to the study, recreational use of any substance was independently associated with a higher likelihood of premature and extremely premature heart disease. Furthermore, those who regularly use 4 or more substances are 9 times as likely to be affected. The investigators also found that patients with premature heart disease were more likely to smoke (63% vs 41%), drink (32% vs 15%), and to use cocaine (13% vs 2.5%), amphetamines (3% vs 0.5%), and cannabis (12.5% vs 3%).

After accounting for potentially influential factors, such as high blood pressure, diabetes, and high cholesterol, those who smoked tobacco were nearly twice as likely to have premature heart disease whereas those who drank recreationally were 50% more likely to do so. Cocaine users were almost 2.5 times as likely to have premature heart disease, whereas amphetamine users were nearly 3 times as likely to do so. Cannabis users were more than 2.5 times likely to have premature heart disease whereas those using other drugs were approximately 2.5 times as likely to do so.

Similar trends were observed among individuals who had extremely premature heart disease, with recreational substance use associated with 1.5 to 3 times higher odds of heart disease. The associations were even stronger among women with premature and extremely premature heart disease than among similarly affected men.

Because this was an observational study, the investigators were unable to determine causality. They also acknowledged that they were unable to gather information on other potentially influential factors, such as the dose and duration of recreational substance use.

Other research has found that the use of cocaine and methamphetamine have been associated with faster cell aging and neurocognitive decline, with higher than average loss of grey matter. Epidemiological studies have also suggested that 1 in 5 young adults misuse several substances and that these polysubstance users often start at younger ages, and therefore have worse health over the long term.

The investigators said these findings demonstrate the need for better education on the potential long-term damage being done to the cardiovascular system in individuals with substance use disorders. People should be aware of the risks beyond those of an overdose and physicians should screen patients with a history of substance misuse, according to the study.

REFERENCE

Drinking, smoking, and drug use linked to premature heart disease in the young [news release]. EurekAlert; February 15, 2021. https://www.eurekalert.org/pub_releases/2021-02/b-dsa021121.php. Accessed February 18, 2021.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Pharmacist and patient -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients
August 15th 2025

After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients

Monica Holmberg, PharmD, BCPS
A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025
August 15th 2025

A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Patient Perceptions Support Co-Management of Chronic Kidney Disease
August 15th 2025

Patient Perceptions Support Co-Management of Chronic Kidney Disease

Helen Pervanas, PharmD
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 15th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Woman doctor nutritionist hands in white shirt with omega 3, vitamin D capsules with green vegan food. The doctor prescribes a prescription for medicines and vitamins at clinic | Image Credit: Galina Zhigalova | stock.adobe.com
August 15th 2025

Mechanistic Rationale and Safety Considerations for the Combined Supplementation of Vitamins D and K

Danielle Valletti, Assistant Editor
Prague,Czech republic-June 17 2024: Jardiance box of medication with Empagliflozin active substance by Boehringer Ingelheim,used for treatment of Type 2 diabetes,Heart failure,Hyperglycemia - Image credit: Semi | stock.adobe.com
August 15th 2025

A Few Key Points Can Guide SGLT2 Inhibitor Management

Jeannette Y. Wick, MBA, RPh, FASCP
Related Content
Advertisement
After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients
August 15th 2025

After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients

Monica Holmberg, PharmD, BCPS
A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025
August 15th 2025

A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Patient Perceptions Support Co-Management of Chronic Kidney Disease
August 15th 2025

Patient Perceptions Support Co-Management of Chronic Kidney Disease

Helen Pervanas, PharmD
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 15th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Woman doctor nutritionist hands in white shirt with omega 3, vitamin D capsules with green vegan food. The doctor prescribes a prescription for medicines and vitamins at clinic | Image Credit: Galina Zhigalova | stock.adobe.com
August 15th 2025

Mechanistic Rationale and Safety Considerations for the Combined Supplementation of Vitamins D and K

Danielle Valletti, Assistant Editor
Prague,Czech republic-June 17 2024: Jardiance box of medication with Empagliflozin active substance by Boehringer Ingelheim,used for treatment of Type 2 diabetes,Heart failure,Hyperglycemia - Image credit: Semi | stock.adobe.com
August 15th 2025

A Few Key Points Can Guide SGLT2 Inhibitor Management

Jeannette Y. Wick, MBA, RPh, FASCP
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.